BRIEF-Neuren Pharmaceuticals Says Daybue Stix Now Broadly Available In US For Rett Syndrome
NewMarket Corporation -0.96%
NewMarket Corporation NEU | 628.74 | -0.96% |
April 8 (Reuters) - Neuren Pharmaceuticals Ltd NEU.AX:
DAYBUE STIX NOW BROADLY AVAILABLE IN US FOR RETT SYNDROME
Further company coverage: NEU.AX
